Take a look at the Recent articles

Antimicrobial dosing error in intermittent & continuous hemodialysis

Saja M. Alhabardi

The Saudi Food and Drug Authority, Riyadh, Saudi Arabia

E-mail : bhuvaneswari.bibleraaj@uhsm.nhs.uk

Maha Almoliki

King Abdulaziz Medical City- Central Region, Riyadh, Saudi Arabia

Albatoul Almeshari

The Saudi Food and Drug Authority, Riyadh, Saudi Arabia

Maha Alammari

King Abdulaziz Medical City- Central Region, Riyadh, Saudi Arabia

DOI: 10.15761/NRD.1000185

Article
Article Info
Author Info
Figures & Data

Abstract

To describe the most commonly prescribed antibiotics in HD patients, identify the most frequently occurring errors during prescribing the antibiotics in HD patients, which include the errors in dosage, or frequency.

Introduction

Antibiotic drugs are the most frequently prescribed medications among hospitalized patients for life-saving purposes, mainly in immunocompromised patient, like in patient with end stage renal disease on hemodialysis (HD) or those who had documented bacterial infection [1]. Antibiotics disposition and their pharmacokinetics and pharmacodynamics properties are affected in hemodialysis patient which increases the number of antibiotics dosing errors [2]. Several epidemiological studies found that the majority of medication error related to antibiotics occurred during the prescribing phase (30.8%) [3,4]. However, there is missing data about the prevalence of errors in antibiotics dosing in HD patients.

Method

An observational retrospective cohort study included around 110 end-stage chronic kidney disease patients on HD over a one-year period (2016 to 2017). We collected the demographic data which included age, gender, height in (cm), weight in (kg), ideal body weight was calculated in patients who received aminoglycosides antibiotics or Colistin, and the antibiotic received including its dose, route, and frequency.

Results

From a total of 110 HD patients were collected, male gender counted for 57.3% of them with an average age 63 years ± 16. Empirical antibiotics were administered to 73.64% HD patients. Cefazolin, piperacillin-tazobactam, ciprofloxacin, and amoxicillin-clavulanic acid were the most frequently prescribed antibiotics in HD patients (26.4%, 16.4%, 13%, and 13%), respectively. However, 27% (n= 30) of HD patents did not receive an appropriately adjusted-dose antibiotics. Medication errors related to prescribing the antibiotics in HD patients mainly occurred with the Meropnem (86%), by receiving it with wrong dose and frequency. Half of HD patients received an inappropriate ciprofloxacin and amoxicillin-clavulanic acid antibiotics regimen, mainly with oral route. The wrong frequency was reported with 71.43% among those who received an oral ciprofloxacin, and 57.14% in those who received oral amoxicillin-clavulanic acid antibiotic.

Conclusion: The result showed that errors in prescribing antibiotics in HD patients are common. The errors mainly occurred with the prescription of meropnem, ciprofloxacin, and from amoxicillin-clavulanic acid antibiotics. This proves that enhancing health care providers’ awareness about appropriate dosing regimens in HD patients is very importance.

References

  1. Furuno JP, Noble BN, Horne KN, McGregor JC, Elman MR, et al. (2014) Frequency of Outpatient Antibiotic Prescription on Discharge to Hospice Care. Antimicrob Agents Chemother 58: 5473-5477. [Crossref]
  2. Heintz BH, Matzke GR, Dager WE (2009) Antimicrobial Dosing Concepts and Recommendations for Critically Ill Adult Patients Receiving Continuous Renal Replacement Therapy or Intermittent Hemodialysis. Pharmacotherapy 29: 562-577. [Crossref]
  3. Rider BB (2016) Prescribing Errors that Cause Harm. Pennsylvania Patient Safety Advisory 13: 81-91.
  4. Bobb A, Gleason K, Husch M, Feinglass J, Yarnold PR, et al. (2004) The epidemiology of prescribing errors: the potential impact of computerized prescriber order entry. Arch Intern Med 164: 785-792. [Crossref]

Editorial Information

Editor-in-Chief

Yohei Miyamoto

Article Type

Research Article

Publication history

Received: May 16, 2021
Accepted: May 26, 2021
Published: May 31, 2021

Copyright

©2021 Alhabardi SM. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Citation

Alhabardi SM, Almoliki M, Almeshari A, Alammari M (2021) Antimicrobial dosing error in intermittent & continuous haemodialysis. Nephrol Renal Dis 6: 1 DOI: 10.15761/NRD.1000185.

Corresponding author

Saja M. Alhabardi

The Saudi Food and Drug Authority, Riyadh, Saudi Arabia.

E-mail : bhuvaneswari.bibleraaj@uhsm.nhs.uk

No data.